Yang J - Search Results

1

Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial.

Kudo M, Han G, Finn RS, Poon RT, Blanc JF, Yan L, Yang J, Lu L, Tak WY, Yu X, Lee JH, Lin SM, Wu C, Tanwandee T, Shao G, Walters IB, Dela Cruz C, Poulart V, Wang JH. Kudo M, et al. Among authors: yang j. Hepatology. 2014 Nov;60(5):1697-707. doi: 10.1002/hep.27290. Epub 2014 Sep 29. Hepatology. 2014. PMID: 24996197 Clinical Trial.

2

Interim analysis of START: Study in Asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trial.

Chung YH, Han G, Yoon JH, Yang J, Wang J, Shao GL, Kim BI, Lee TY, Chao Y. Chung YH, et al. Among authors: yang j. Int J Cancer. 2013 May 15;132(10):2448-58. doi: 10.1002/ijc.27925. Epub 2012 Nov 28. Int J Cancer. 2013. PMID: 23129123 Free article. Clinical Trial.

3

Sorafenib in combination with transarterial chemoembolization in Chinese patients with hepatocellular carcinoma: a subgroup interim analysis of the START trial.

Han G, Yang J, Shao G, Teng G, Wang M, Yang J, Liu Z, Feng G, Yang R, Lu L, Chao Y, Wang J. Han G, et al. Among authors: yang r, yang j. Future Oncol. 2013 Mar;9(3):403-10. doi: 10.2217/fon.13.11. Future Oncol. 2013. PMID: 23469975 Clinical Trial.

4

The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: final results of the START trial.

Chao Y, Chung YH, Han G, Yoon JH, Yang J, Wang J, Shao GL, Kim BI, Lee TY. Chao Y, et al. Among authors: yang j. Int J Cancer. 2015 Mar 15;136(6):1458-67. doi: 10.1002/ijc.29126. Epub 2014 Sep 16. Int J Cancer. 2015. PMID: 25099027 Free article. Clinical Trial.

5

The role of hepatic resection in the treatment of hepatocellular cancer.

Roayaie S, Jibara G, Tabrizian P, Park JW, Yang J, Yan L, Schwartz M, Han G, Izzo F, Chen M, Blanc JF, Johnson P, Kudo M, Roberts LR, Sherman M. Roayaie S, et al. Among authors: yang j. Hepatology. 2015 Aug;62(2):440-51. doi: 10.1002/hep.27745. Epub 2015 Mar 20. Hepatology. 2015. PMID: 25678263

6

Safety and efficacy of sorafenib therapy in patients with hepatocellular carcinoma: final outcome from the Chinese patient subset of the GIDEON study.

Ye SL, Chen X, Yang J, Bie P, Zhang S, Liu F, Liu L, Zhou J, Dou K, Hao C, Shao G, Xia Q, Chen Y, Yang J, Deng X, Liu Y, Yuan Y, Fu Z, Nakajima K, Yip CS, Lu Z. Ye SL, et al. Among authors: yang j. Oncotarget. 2016 Feb 9;7(6):6639-48. doi: 10.18632/oncotarget.6781. Oncotarget. 2016. PMID: 26735891 Free PMC article. Clinical Trial.

7

Patterns of sorafenib and TACE treatment of unresectable hepatocellular carcinoma in a Chinese population: subgroup analysis of the GIDEON study.

Liu F, Meng Z, Shao G, Wang J, Wang Z, Yang J, Yip CS, He D. Liu F, et al. Among authors: yang j. Mol Biol Rep. 2017 Feb;44(1):149-158. doi: 10.1007/s11033-016-4092-x. Epub 2016 Dec 15. Mol Biol Rep. 2017. PMID: 27981445

8

Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON study.

Ye SL, Yang J, Bie P, Zhang S, Chen X, Liu F, Liu L, Zhou J, Dou K, Hao C, Shao G, Xia Q, Chen Y, Yang J, Deng X, Liu Y, Yuan Y, Fu Z, Nakajima K, Lv Z. Ye SL, et al. Among authors: yang j. BMC Cancer. 2018 Mar 2;18(1):247. doi: 10.1186/s12885-018-4144-9. BMC Cancer. 2018. PMID: 29499662 Free PMC article.

9

Efficacy and safety of raltitrexed-based transarterial chemoembolization for colorectal cancer liver metastases.

Shao G, Liu R, Ding W, Lu L, Li W, Cao H, Liu R, Li C, Xiang H, Yang Z, Yang J, Song J, Wang J. Shao G, et al. Among authors: yang z, yang j. Anticancer Drugs. 2018 Nov;29(10):1021-1025. doi: 10.1097/CAD.0000000000000690. Anticancer Drugs. 2018. PMID: 30134285

10

[Effects of Jinlong Capsule on expressions of interleukin-2 and soluble interleukin-2 receptor in patients with primary liver cancer after transarterial chemoembolization therapy].

Zhang HJ, Yang JJ, Wang WX, Jiang X, Mao YJ, Yang CA, Guo JX. Zhang HJ, et al. Zhong Xi Yi Jie He Xue Bao. 2008 Sep;6(9):907-10. doi: 10.3736/jcim20080906. Zhong Xi Yi Jie He Xue Bao. 2008. PMID: 18782532 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84,488 results

Search Page